SCHEMBL23254402

SCHEMBL23254402

N/C=C\N(N)c1ccc(SN)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16782403 0.76 ALDH1A1 (0.42) —
SCHEMBL171934 0.74 ALDH1A1 (0.42) —
SCHEMBL22359864 0.71 HRH3 (0.41) —
SCHEMBL21792294 0.69 TYR (0.38) —
SCHEMBL20852278 0.69 TAAR1 (0.39) —
SCHEMBL22359687 0.68 ADRB2 (0.42) —
SCHEMBL22359670 0.67 MAPT (0.43) —
SCHEMBL4304154 0.66 ALDH1A1 (0.58) —
SCHEMBL19674446 0.63 CYP2E1 (0.30) —
SCHEMBL14981502 0.61 CYP3A4 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3277286-B1 BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF ENANTA PHARM INC (US) 2021-04-21 — — EP disclosed
Send feedback